Vivos Therapeutics Inc (VVOS) Annual Balance Sheets

Annual · GAAP · USD millions
Access VVOS quarterly Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Vivos Therapeutics Inc's financial structure and capital allocation.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent2.03
Cash & Short-term Investments2.00
Accounts receivable1.58
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.77
Total Current Assets4.38
Equipment/Property/Plant Net3.76
Goodwill net8.57
Intangible Assets4.05
Deposits Assets, Noncurrent AS0.23
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset4.17
Total Assets25.15
Liabilities
Accounts Payable, Current AC1.68
Accrued Liabilities, Current AC5.99
Long-term Debt, Current Maturities LO8.35
Other Liabilities, Current2.06
Deferred Rent Credit, Current DE0.00
Total Current Liabilities18.08
Long-term debt0.47
Total Long-term Debt0.47
Deferred Rent Credit, Noncurrent DE0.00
Other liabilities, Noncurrent8.16
OperatingLeaseLiabilityNoncurrent3.84
Contract With Customer Liability Current0.48
Total Liabilities26.70
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock123.87
Retained Earnings / Accumulated Deficit-125.36
Other Equity-0.12
Common Stockholder's Equity-1.61
Non-controlling interests & other0.06
Total Stockholder's Equity-1.55
Liabilities & Stockholder's Equity25.15
4 historic quarters locked

Sign in to unlock the full Vivos Therapeutics Inc balance sheet history.

About Vivos Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: April 15, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-016854

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.